COVID-19: treating and managing severe cases

Cell Res. 2020 May;30(5):370-371. doi: 10.1038/s41422-020-0329-2.

Authors

Jingwen Ai¹, Yang Li¹, Xian Zhou¹, Wenhong Zhang²

Affiliations

¹ Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, 200040, China.
² Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, 200040, China. zhangwenhong@fudan.edu.cn.

No abstract available

MeSH terms

Antiviral Agents / therapeutic use
COVID-19
Coronavirus Infections / epidemiology
Coronavirus Infections / therapy*
Disease Management
Disease Progression
Glucocorticoids / therapeutic use
Humans
Pandemics
Pneumonia, Viral / epidemiology
Pneumonia, Viral / therapy*

Substances

Antiviral Agents
Glucocorticoids